Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041079 | SCV000064770 | uncertain significance | not specified | 2012-05-10 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Pathogenic. The Asp3648fs v ariant in TTN has not been reported in the literature nor previously identified by our laboratory. This frameshift variant is predicted to alter the protein?s a mino acid sequence beginning at position 3648 and lead to a premature terminatio n codon 22 amino acids downstream. Heterozygous loss of function of the TTN gene is strongly associated with DCM (Herman 2012). The available evidence suggests that the Asp3648fs variant may be pathogenic but additional studies are needed t o fully assess its clinical significance. |
Blueprint Genetics | RCV000208072 | SCV000264295 | uncertain significance | Left ventricular noncompaction cardiomyopathy | 2015-04-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149666 | SCV003838668 | likely pathogenic | Cardiomyopathy | 2021-10-01 | criteria provided, single submitter | clinical testing |